Kevin
専門分野
Kevin Chang is the head of our Greater China Healthcare practice and a member of our Private Equity practice, based in Hong Kong.
Kevin regularly advises clients on organization, strategy and transformation, as well as both commercial and launch excellence. His recent client engagements have involved due diligence and sector screening and review efforts for private equity clients, as well as adjacency and business unit strategy across pharmaceuticals and biotechnology.
While with the firm, Kevin has led a commercial excellence exercise for one of the world's leading IVD manufacturers, which doubled the company’s business in China in 5 years.
He is also deeply involved with our local pro bono efforts.
Kevin holds a B.A. in Economics from Cornell University.
Recent Insights
- “The New Board Agenda,” 論説, 2021年10月19日
- “China, Deglobalization, and the Multinational,” 記事, 2021年7月21日
- “Local Innovation Is Fueling Asia-Pacific’s Healthcare Private Equity Boom,” 動画, 2021年4月28日
- “Healthcare Private Equity in Asia-Pacific Rides a Wave of Domestic Innovation ,” スナップチャート, 2021年3月23日
- “Healthcare Private Equity in Asia-Pacific: Riding a Wave of Domestic Innovation,” レポート, 2021年3月16日